Viral Infections, Are They a Trigger and Risk Factor of Alzheimer's Disease?

被引:5
作者
Rippee-Brooks, Meagan D. [1 ]
Wu, Wenzhe [2 ]
Dong, Jianli [3 ]
Pappolla, Miguel [4 ,5 ]
Fang, Xiang [4 ,5 ]
Bao, Xiaoyong [1 ,2 ,6 ,7 ]
机构
[1] Univ Texas Med Branch, Dept Microbiol & Immunol, Microbiol & Immunol Grad Program, Galveston, TX 77550 USA
[2] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77550 USA
[3] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77550 USA
[4] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77550 USA
[5] Univ TexasMed Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77550 USA
[6] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77550 USA
[7] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77550 USA
来源
PATHOGENS | 2024年 / 13卷 / 03期
关键词
Alzheimer's Disease; AD pathology; virus-AD hypothesis; Zika; herpesvirus; SARS-CoV-2; influenza; SIMPLEX-VIRUS TYPE-1; AMYLOID PRECURSOR PROTEIN; BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; ZIKA VIRUS; MOUSE MODEL; HIV; TAU; IDENTIFICATION; CYTOMEGALOVIRUS;
D O I
10.3390/pathogens13030240
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Alzheimer's Disease (AD), a progressive and debilitating condition, is reported to be the most common type of dementia, with at least 55 million people believed to be currently affected. Many causation hypotheses of AD exist, yet the intriguing link between viral infection and its possible contribution to the known etiology of AD has become an attractive focal point of research for the field and a challenging study task. In this review, we will explore the historical perspective and milestones that led the field to investigate the viral connection to AD. Specifically, several viruses such as Herpes Simplex Virus 1 (HSV-1), Zika virus (ZIKV), and severe cute respiratory syndrome coronavirus 2 (SARS-CoV-2), along with several others mentioned, include the various viruses presently considered within the field. We delve into the strong evidence implicating these viruses in the development of AD such as the lytic replication and axonal transport of HSV-1, the various mechanisms of ZIKV neurotropism through the human protein Musashi-1 (MSI1), and the spread of SARS-CoV-2 through the transfer of the virus through the BBB endothelial cells to glial cells and then to neurons via transsynaptic transfer. We will also explore beyond these mere associations by carefully analyzing the potential mechanisms by which these viruses may contribute to AD pathology. This includes but is not limited to direct neuronal infections, the dysregulation of immune responses, and the impact on protein processing (A beta 42 and hyperphosphorylated tau). Controversies and challenges of the virus-AD relationship emerge as we tease out these potential mechanisms. Looking forward, we emphasize future directions, such as distinct questions and proposed experimentations to explore, that the field should take to tackle the remaining unanswered questions and the glaring research gaps that persist. Overall, this review aims to provide a comprehensive survey of the past, present, and future of the potential link between viral infections and their association with AD development while encouraging further discussion.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Links between copper and cholesterol in Alzheimer's disease
    Hung, Ya Hui
    Bush, Ashley I.
    La Fontaine, Sharon
    FRONTIERS IN PHYSIOLOGY, 2013, 4
  • [42] Alzheimer's Disease Risk Genes and Lipid Regulators
    El Gaamouch, Farida
    Jing, Ping
    Xia, Jiahong
    Cai, Dongming
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (01) : 15 - 29
  • [43] Immunotherapy for Alzheimer's disease
    Morgan, D.
    JOURNAL OF INTERNAL MEDICINE, 2011, 269 (01) : 54 - 63
  • [44] Early life adversity as a risk factor for cognitive impairment and Alzheimer's disease
    Huang, Zhihai
    Jordan, J. Dedrick
    Zhang, Quanguang
    TRANSLATIONAL NEURODEGENERATION, 2023, 12 (01)
  • [45] Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer's disease
    Dey, Mangaldeep
    Singh, Rakesh Kumar
    PHARMACOLOGICAL REPORTS, 2022, 74 (03) : 439 - 450
  • [46] Ischemia as a common trigger for Alzheimer's disease
    Elman-Shina, Karin
    Efrati, Shai
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [47] Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?
    Zhuo, Jia-Min
    Wang, Hong
    Pratico, Domenico
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (09) : 562 - 571
  • [48] Viral Hypothesis and Antiviral Treatment in Alzheimer’s Disease
    D. P. Devanand
    Current Neurology and Neuroscience Reports, 2018, 18
  • [49] Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease
    Devanand, D. P.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (09)
  • [50] Alzheimer's disease: an axonal injury disease?
    Dan, Liang
    Zhang, Zhaohui
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15